accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

From: Bergmann, Kenneth {OO}
Sent: Saturday, April 4, 2020 9:39 AM

To: Fauci, Anthony (NIH/NIAID) (E] [OY >

Subject: a thought on selective vulnerability to SARS-CoV-2

Dear Dr. Fauci
| read with interest your JAMA Viewpo:nt of February 25.

Thank you for all you do.
Sincerely
Ken

Kenneth J. Bergmann, MD, FAAN

Senior Medical Officer

Division of Neurology |, Office of Neuroscience
Center for Drug Evaluation and Research

U.S. Food and Drug Administration

Building 22, Room 4143

10903 New Hampshire Avenue,

Silver Spring, MD 20993-0002

Office: (b) (Oy
Mobile:

 
